Notably, Inamura et al. found that only 37 out of 252 ccRCC cases (15%) demonstrated high CD276 expression within tumor cells; however, 137 samples (54%) displayed elevated expression levels in the tumor vasculature. The gene discussed is CD276; the disease is neoplasm.